Integra LifeSciences Reports Fourth Quarter 2013 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Integra Lifesciences Holdings (IART) Misses Q4 EPS by 3c
February 25, 2014 6:36 AM ESTIntegra Lifesciences Holdings (NASDAQ: IART) reported Q4 EPS of $0.78, $0.03 worse than the analyst estimate of $0.81. Revenue for the quarter came in at $220.8 million versus the consensus estimate of $223.37 million.
Integra Lifesciences Holdings sees FY2014 revenue of $920-940 million, versus the consensus of $932.3 million.... More



